Effect of Dietary Salt Supplemantation in Vasovagal Syncope Prophylaxis: A Clinical Trial
This trial is active, not recruiting.
|Sponsor||Hospital de Clinicas de Porto Alegre|
|Start date||June 2004|
|End date||June 2007|
|Trial size||20 participants|
|Trial identifier||NCT00465946, HCPA04-071|
Syncope is a syndrome consisting of a relatively short period of temporary and self-limited loss of consciousness caused by transient diminution of blood flow to the brain (most often the result of systemic hypotension). The objective of this study was to evaluate the effect of salt supplementation in vasovagal syncope prophylaxis.
|Endpoint classification||efficacy study|
|Intervention model||crossover assignment|
Evaluate the effectiveness of the salt supplementation in the prophylaxis of the vasovagal syncope
Evaluate the supplementation salt increases the orthostatic tolerance
Analyze the supplementation salt increases the plasmatic volume
Male or female participants from 18 years up to 40 years old.
Inclusion Criteria: - Healthy volunteers Exclusion Criteria: - Use medicines - Previous diseases - Incapacity of to understand and to sign the term consent
|Official title||Effect of Dietary Salt Supplemantation in Vasovagal Syncope Prophylaxis: A Clinical Trial|
|Principal investigator||Leandro I Zimerman, MD|
|Description||Healthy volunteers without use of medicines with except contraceptives orals that met the exclusion criteria were consecutively enrolled in a randomized trial.|
Call for more information